This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Medigene Ag, Fougera Pharmaceuticals Inc., Other. Active years: 2009-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Stockdorf, DE (2009 - 2017)
- Münster, DE (2019)
Company Filing History:
2 out of 48 
1 out of 4 
1 out of 834,570 Years Active: 2009-2019
Title: **Irene Gander-Meisterernst: Innovator in Medicinal Chemistry**
Introduction
Irene Gander-Meisterernst is a prominent inventor located in Stockdorf, Germany, recognized for her significant contributions to the field of medicinal chemistry. With a total of four patents to her name, she has made remarkable strides in the development of medicaments aimed at treating viral skin and tumor diseases.
Latest Patents
Her latest invention is a novel medicament designed specifically for the treatment of viral skin and tumor diseases. This invention relates to a compound characterized by a complex structural formula, which includes various alkyl, alkylene, or alkinyl groups. The medicament serves as a therapeutic agent, either alone or in combination with other pharmaceutical agents, specifically targeting ailments caused by human papilloma virus (HPV) and herpes viruses. This innovative formulation aims to provide effective treatment through a topically acting medicament.
Career Highlights
Throughout her career, Irene has gained valuable experience working with notable organizations like Medigene AG and Fougera Pharmaceuticals Inc. These positions have allowed her to refine her research and development skills, contributing to her expertise in creating effective medicinal products.
Collaborations
Irene’s work has seen her collaborate with talented professionals in her field, including colleagues such as Yunik Chang and Robert Lathrop. These collaborations have enriched her research endeavors, driving forward innovation in therapeutic development.
Conclusion
Irene Gander-Meisterernst stands out as a dedicated inventor whose innovations have the potential to substantially impact the treatment options available for viral skin and tumor diseases. Her ongoing efforts in the field of medicinal chemistry promise to contribute to the advancement of healthcare solutions and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile